The store will not work correctly when cookies are disabled.
(R)-4-propyl-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,8]naphthyridine
ID: ALA4765074
PubChem CID: 134265828
Max Phase: Preclinical
Molecular Formula: C14H21N3
Molecular Weight: 231.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCCc1ccnc2c1CC[C@@H]1CNCCN21
Standard InChI: InChI=1S/C14H21N3/c1-2-3-11-6-7-16-14-13(11)5-4-12-10-15-8-9-17(12)14/h6-7,12,15H,2-5,8-10H2,1H3/t12-/m1/s1
Standard InChI Key: XAZGRAYUJBLSIW-GFCCVEGCSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
11.0183 -11.8121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0171 -12.6316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7252 -13.0406 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7234 -11.4032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4320 -11.8085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4354 -12.6337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8580 -11.8026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1410 -11.3907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8613 -12.6278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1455 -13.0392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1437 -13.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8562 -14.2762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5721 -13.8649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5755 -13.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5650 -12.2125 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
11.7210 -10.5860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4274 -10.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4250 -9.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 10 1 0
9 7 1 0
7 8 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
9 15 1 1
4 16 1 0
16 17 1 0
17 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 231.34 | Molecular Weight (Monoisotopic): 231.1735 | AlogP: 1.76 | #Rotatable Bonds: 2 |
Polar Surface Area: 28.16 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.94 | CX LogP: 2.87 | CX LogD: 1.32 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.84 | Np Likeness Score: -0.12 |
References
1. Schrader TO,Zhu X,Kasem M,Ren A,Liu C,Wu C,Dang H,Le M,Gatlin J,Chase K,Frazer J,Whelan KT,Grottick AJ,Hutton C,Barden J,Chen C,Ortiz A,Feichtinger K,Semple G. (2021) Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT receptor., 38 [PMID:33636307] [10.1016/j.bmcl.2021.127872] |